European researchers have designed two new vaccine candidates to fight the HIV virus. These have been developed within the EU-funded project EURONEUT 41 .

AIDS research has attempted many strategies to tackle the HIV virus infection. Now, a new type of vaccine developed within an EU-funded project, called EuroNeut-41 , is based on one of the envelope proteins of the HIV virus , called the gp41 protein.

HIV is still plaguing humanity with 35 million infected people worldwide. Antiretroviral drugs do slow down the progression of the disease but at a high cost and with long term toxicity.

Despite being such a common problem, the decision-making process regarding the treatment of lumbar or low back pain is slow and it is hard for clinicians to decide if a patient actually requires a surgical treatments and to predict if these will be successful.

From 13th to 16th September 13 to 16 Barcelona hosted the 2011 ISEE (International Society for Environmental Epidemiology) congress.

Nevertheless Margulis is best known for her theory of symbiogenesis, which challenges a central tenet of neodarwinism.